Phase II study of combination human recombinant GM‐CSF with intermediate‐dose cytarabine and mitoxantrone chemotherapy in patients with high‐risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study
暂无分享,去创建一个
W. Hiddemann | J. Liesveld | H. Lazarus | E. Paietta | J. Rowe | R. Marsh | F. A. Hayes | J. Bennett | K. B. Miller | Gordon W. Dewald | William R. Friedenberg | Mary S. Young | Hussain T. Saba